Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis

Osteoarthritis and Cartilage

Volumn 8, Issue 3, 2000, Pages 213-221

  Westacott, C I ^a   Barakat, A F ^a   Wood, L ^a   Perry, M J ^a   Neison, P ^a   Bisbinas, I ^a   Armstrong, L ^a   Millar, A B ^a   Elson, C J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cartilage; Osteoarthritis; Soluble tumor necrosis factor receptors (sTNF R); Tumor necrosis factor alpha (TNF )

Indexed keywords

GLYCOSAMINOGLYCAN; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL LOSS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNOVIUM;

EID: 0034124588     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1999.0292     Document Type: Article

References (27)

1. Arner EC, Hughes CE, Decicco CP, Caterson B, Tortorella MD. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage. 6:1998;214-228.
2. Fosang AJ, Last K, Maciewicz RA. Aggrecan is degraded by matrix metalloproteinases in human arthritis. J Clin Invest. 98:1996;2292-2299.
3. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Annals Rheum Dis. 49:1990;676-681.
4. Elson CJ, Mortuza FY, Perry MJ, Warnock MG, Webb GR, Westacott CI. Cytokines and focal loss of cartilage in osteoarthritis. Brit J Rheum. 37:1998;106-107.
5. Warnock, MG, Mechanisms of cartilage degradation in osteoarthritis, Bristol University, 1995.
6. Ismaiel SI, Atkins RM, Pearse MF, Dieppe PA, Elson CJ. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Brit J Rheum. 31:1992;369-373.
7. Webb GR, Westacott CI, Elson CJ. Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage. 5:1997;427-437.
8. Martell-Pelletier J, McCollum R, DiBattista J. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Arthritis Rheum. 35:1992;530-540.
9. Westacott CI, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol. 21:1994;1710-1715.
10. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones A. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic disease. Arthritis Rheum. 35:1992;1160-1169.
11. Farndale RW. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta. 883:1986;173-177.
12. Webb GR, Westacott CI, Elson CJ. Osteoarthritic synovial fluid and synovium supernatants upregulate tumor necrosis factor receptors on human articular chondrocytes. Osteoarthritis Cartilage. 6:1998;167-176.
13. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum. 40:1997;1282-1291.
14. Bailey M, Williams NA, Wilson AD, Stokes CR. PROBIT: weighted regression analysis for estimation of biological activity. J Immunological Methods. 153:1992;261-262.
15. Armstrong L, Foley NM, Millar AB. Inter-relationship between tumour necrosis factor alpha (TNFα) and TNF soluble receptors in pulmonary sarcoidosis. Thorax. 54:1999;524-530.
16. Hauselmann HJ, Flechtenmacher J, Michal L, Thonar EJ-MA, Shinmei M, Kuettner KE, Aydelotte MB. The superficial layer of human articular cartilage is more susceptible to interleukin-1 induced damage than the deeper layers. Arthritis Rheum. 39:1996;478-488.
17. Kammerman JR, Kincaid SA, Rumph PF, Baird DK, Visco DM. Tumor necrosis factor-α in canine osteoarthritis: immunolocalisation of TNFα, stromelysin and TNFα receptors in canine osteoarthritic cartilage. Osteoarthritis Cartilage. 4:1996;23-34.
18. Aderka D, Engelmann H, Shemer-Avni Y. Variation in serum levels of the soluble TNFa receptors among healthy individuals. Lymphokine and cytokine Research. 3:1992;157-159.
19. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kustai G. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Research. 51:1991;5602-5607.
20. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldower LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-a in vitro and in vivo. Proc Natl Acad Sci. 89:1992;4845-4849.
21. Alaaeddine N, DiBattista JA, Pelletier J-P, Cloutier J-M, Kiansa K, Dupois M, Martel-Pelletier J. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNFα J Rheumatol. 24:1997;1985-1994.
22. Joyce DA, Steer JH. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNFα receptors but not p55 TNFα receptors from human monocytes. J Interferon Cytokine Res. 15:1995;947-954.
23. Aderka D, Sorkine P, Abu-Abid S, Lev D, Setton A, Cope AP, Wallach D, Klausner J. Shedding kinetics of soluble tumor necrosis factor (TNFα) receptors after systemic TNFα leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest. 101:1998;650-659.
24. Moos V, Fickert S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol. 26:1999;870-879.
25. Urban JPG, Hall AC, Gehl KA. Regulation of synthesis in articular chondrocytes by extracellular osmolality and ionic composition. J Cell Physiol. 154:1993;262-270.
26. Mohtai M, Gupta MK, Donlan B. Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vivo. J Bone Joint Surgery. 14:1993;67-73.
27. Cameron ML, Frondoza CG, Holland C. Hungerford DSH Expression of proinflammatory IL-1 and TNFα by osteoarthritic chondrocytes is altered in response to mechanical stress. Trans Orthop Res Soc. 24:1999;606.